论文部分内容阅读
Telaprevir正在开创丙肝治疗的新时代,它可特异性的针对HCV病毒蛋白酶,抑制其活性,阻止病毒的活化与复制。其良好的疗效或将造就丙肝治疗的第4次历史性飞跃。
Telaprevir is embarking on a new era of hepatitis C treatment that specifically targets the HCV viral protease, inhibits its activity and prevents the activation and replication of the virus. Its good effect or will create the fourth historic leap in the treatment of hepatitis C.